Researchers at the meeting reported on long-term activity of commercialized gene therapies and preliminary data on ...

Selinexor with ruxolitinib demonstrated encouraging efficacy with a manageable safety profile in patients with myelofibrosis who were previously treated with ruxolitinib.

The majority of SCD patients given Lyfgenia in clinical trials remained free of vaso-occlusive events (VOEs) following ...

Comedian Munawar Faruqui recently revealed his financial struggles while treating his son Mikael, diagnosed with Kawasaki ...

J&J aims to expand Darzalex's use even further in the blood cancer, while Merck & Co. and Novo Nordisk presented at ASH ...

Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting ...

A lengthy treatment process, coupled with weighty risks for recipients to consider, has resulted in plodding adoption of ...

People wanting to make a lifesaving difference in Bucks County have the chance to donate blood and platelets at the new ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced longer-term data for CASGEVY™ (exagamglogene autotemcel) from global clinical trial ...

An innovative combination of readily available natural products has shaped up to be an alternative to drugs like Ozempic to ...